Skip to main content
Figure 5 | Virology Journal

Figure 5

From: Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner

Figure 5

Rapamycin treatment does not alter EBV-positive cell viability, but does decrease cell proliferation. Raji, EBfaV-GFP, and AGS-BDneo cells were left untreated or treated with 5 nM rapamycin for 24 hr prior to induction of lytic replication, as indicated. 24 hr later the viability of cells and cell density were determined by flow cytometry. The percentage of viable cells is presented in A, the cell density (total cells/ml) is presented in B.

Back to article page